Diffuse Cutaneous Leishmaniasis Acquired in Peru

Eileen D. Franke U.S. Naval Medical Research Institute Detachment—Lima, Centro Medico Naval, Institute of Pathology, Universidad Nacional Mayor de San Marcos, APO Miami, FL 34031, Peru

Search for other papers by Eileen D. Franke in
Current site
Google Scholar
PubMed Close
,
Carmen M. Lucas U.S. Naval Medical Research Institute Detachment—Lima, Centro Medico Naval, Institute of Pathology, Universidad Nacional Mayor de San Marcos, APO Miami, FL 34031, Peru

Search for other papers by Carmen M. Lucas in
Current site
Google Scholar
PubMed Close
,
Adolfo A. Tovar U.S. Naval Medical Research Institute Detachment—Lima, Centro Medico Naval, Institute of Pathology, Universidad Nacional Mayor de San Marcos, APO Miami, FL 34031, Peru

Search for other papers by Adolfo A. Tovar in
Current site
Google Scholar
PubMed Close
,
J. Hever Kruger U.S. Naval Medical Research Institute Detachment—Lima, Centro Medico Naval, Institute of Pathology, Universidad Nacional Mayor de San Marcos, APO Miami, FL 34031, Peru

Search for other papers by J. Hever Kruger in
Current site
Google Scholar
PubMed Close
,
M. Violeta Seminario De Rivera U.S. Naval Medical Research Institute Detachment—Lima, Centro Medico Naval, Institute of Pathology, Universidad Nacional Mayor de San Marcos, APO Miami, FL 34031, Peru

Search for other papers by M. Violeta Seminario De Rivera in
Current site
Google Scholar
PubMed Close
, and
F. Stephen Wignall U.S. Naval Medical Research Institute Detachment—Lima, Centro Medico Naval, Institute of Pathology, Universidad Nacional Mayor de San Marcos, APO Miami, FL 34031, Peru

Search for other papers by F. Stephen Wignall in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1990.43.260
Volume/Issue:
Volume 43: Issue 3
Page(s):
260–262
Restricted access
Get Permissions

A case of diffuse cutaneous leishmaniasis (DCL) acquired in Peru is described. The causative agent was Leishmania mexicana amazonensis as determined by isoenzyme analysis and species-specific monoclonal antibody binding characteristics. Histological examination of biopsy material showed a large number of intracellular and extracellular amastigotes and few lymphocytes. Treatment with meglumine antimoniate (Glucantime) administered iv at a dosage of 20 mg antimony/kg body weight/day for 60 days resulted in visible improvement of the lesions, but not in clinical or parasitological cure.

Author Notes

Copyright:
Copyright © 1990 by The American Society of Tropical Medicine and Hygiene 1990
Published Online:
Sep 1990
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 893 629 84
Full Text Views 16 2 0
PDF Downloads 17 3 0
 
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save